Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource

  • 888 Accesses

  • 126 Citations

The freely accessible web resource PASS Online is presented. This resource is designed for the prediction of the biological activity spectra of organic compounds based on their structural formulas for more than 4000 types of biological activity with average accuracy above 95% (http://www.way2drug.com/passonline). The prediction is based on an analysis of the structure-activity relationships in the training set containing information on the structure and biological activity of more than 300000 organic compounds. The possibilities and limitations of this approach are described. Recommendations are given for interpreting the prediction results. Examples are given for the practical use of the PASS Online web resource in order to establish priorities for chemical synthesis and biological testing of substances on the basis of prediction results. The further trends are considered for the using PASS Online as an Internet platform for joint projects of academic researchers for the search and development of new pharmaceutical agents.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    http://www.chemnavigator.com/cnc/products/iRL.asp.

  2. 2.

    L. Ruddigkeit, L. C. Blum, and J.-L. Reymond, J. Chem. Inf. Model., 53, 56 (2013).

  3. 3.

    Thomson Reuters Integrity SM, http://integrity.thomson-pharma.com.

  4. 4.

    A. L. Hopkins, Nat. Chem. Biol., 4, 682 (2008).

  5. 5.

    R. Morphy and Z. Rankovic, J. Med. Chem., 49, 4961 (2006).

  6. 6.

    I. M. Kapetanovic, Chem.-Biol. Interact., 171, 165 (2008).

  7. 7.

    C. G. Wermuth (editor), The Practice of Medicinal Chemistry, Third Edition, Academic Press, San Diego (2008).

  8. 8.

    C. Hansch, Acc. Chem. Res., 26, 147 (1993).

  9. 9.

    R. Franke, Theoretical Drug Design Methods, Akademie-Verlag, Berlin (1984), p. 382.

  10. 10.

    V. V. Avidon, Khim.-Farm. Zh., 8, 22 (1974).

  11. 11.

    V. V. Avidon and V. S. Arolovich, Nauchno-Tekhnicheskaya Informatsiya, Ser. 2, No. 5, 26 (1975).

  12. 12.

    V. V. Avidon, V. S. Arolovich, V. G. Blinova, S. P. Kozlova, and A. M. Freidina, Khim.-Farm. Zh., 17, 321 (1983).

  13. 13.

    V. V. Avidon, V. S. Arolovich, S. P. Kozlova, and L. A. Piruzyan, Khim.-Farm. Zh., 12, No. 5, 88 (1978).

  14. 14.

    V. V. Avidon, V. S. Arolovich, S. P. Kozlova, and L. A. Piruzyan, Khim.-Farm. Zh., 12, No. 6, 99 (1978).

  15. 15.

    V. E. Golender and A. B. Rozenblit, Avtomatika i Telemekhanika, 11, 99 (1974).

  16. 16.

    V. E. Golender and A. B. Rozenblit, Computer Methods for Drug Design [in Russian], Zinatne, Riga (1978).

  17. 17.

    V. E. Golender and A. B. Rozenblit, Zh. Vses. Khim. Obshch. Im. D. I. Mendeleeva, 25, No. 1, 28 (1980).

  18. 18.

    A. B. Rozenblit and V. E. Golender, Logic-combinatorial Methods in Drug Design [in Russian], Zinatne, Riga (1984).

  19. 19.

    L. A. Piruzyan, V. V. Avidon, A. B. Rozenblit, V. S. Arolovich, V. E. Golender, S. P. Kozlova, E. M. Mikhailovskii, and E. G. Gavrishchuk, Khim.-Farm. Zh., 11, 35 (1977).

  20. 20.

    V. V. Avidon, I. A. Pomerantsev, V. E. Golender, and A. B. Rozenblit, J. Chem. Inf. Comput. Sci., 22, 207 (1982).

  21. 21.

    V. V. Avidon and L. A. Leksina, Nauchno-Tekhnicheskaya Informatsiya, Ser. 2, No. 3, 22 (1975).

  22. 22.

    N. Veretennikova, A. Skorova, V. Kudryashova, A. Rozenblit, A. Barkans, Ya. Betinsh, V. Drboglav, L. Gitlina, Ya. Grinfelds, P. Mellis, D. Petersone, and V. Shatokhin, in: F. Chen and G. Schüürmann (editors), Quantitative Structure-Activity Relationships in Environmental Sciences, SETAC, Pensacola (1997), p. 115.

  23. 23.

    G. M. Barenboim, L. A. Piruzyan, and A. G. Malenkov, Vestn. Akad. Nauk SSSR, No. 2, 50 (1977).

  24. 24.

    L. A. Piruzyan, A. G. Malenkov, and G. M. Barenboim, Chemical Aspects of Human Activities and Nature Conservation [in Russian], Preprint, Otdel. Inst. Khim. Fiz. Akad. Nauk SSSR, Chernogolovka (1979).

  25. 25.

    G. M. Barenboim and A. G. Malenkov, Biologically Active Compounds. New Search Principles [in Russian], Nauka, Moscow (1986).

  26. 26.

    Yu. V. Burov, L. V. Korol'chenko, and V. V. Poroikov, Byull. Vses. Nauchn. Tsentra po Bezopasnosti Biologicheski Aktivnykh Veshchestv, No. 1, 4 (1990).

  27. 27.

    V. V. Poroikov, D. A. Filimonov, and A. P. Budunova, Nauchno-tekhnicheskaya Informatsiya, Ser. 2, No. 6, 11 (1993).

  28. 28.

    D. A. Filimonov, V. V. Poroikov, E. I. Karaicheva, R. K. Kazaryan, A. P. Budunova, E. M. Mikhailovskii, A. V. Rudnitskikh, L. V. Goncharenko, and Yu. V. Burov, Eksperimental'naya i Klinicheskaya Farmakologiya, 58, No. 2, 56 (1995).

  29. 29.

    D. A. Filimonov and V. V. Poroikov, in: M. G. Ford, R. Greenwood, G. T. Brooks, and R. Franke (editors), Bioactive Compound Design: Possibilities for Industrial Use, BIOS Scientific Publishers, Oxford (1996), p. 47.

  30. 30.

    T. A. Gloriozova, D. A. Filimonov, A. A. Lagunin, and V. V. Poroikov, Khim.-farm. Zh., 32, No. 12, 33 (1998).

  31. 31.

    A. V. Stepanchikova, A. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Curr. Med. Chem., 10, 225 (2003).

  32. 32.

    D. A. Filimonov and V. V. Poroikov, Ros. Khim. Zh., L, No. 2, 66 (2006).

  33. 33.

    D. A. Filimonov and V. V. Poroikov, in: A. Varnek and A. Tropsha (editors), Chemoinformatics Approaches to Virtual Screening, RSC Publishing, Cambridge (2008), p. 182.

  34. 34.

    D. A. Filimonov, V. V. Poroikov, T. A. Gloriozova, and A. A. Lagunin, Certificate for the Official Registration of the PASS Computer Program No. 2006613275, September 15, 2006 [in Russian], Federal Service for Intellectual Property, Patents, and Trademarks, Moscow.

  35. 35.

    D. Filimonov, V. Poroikov, Yu. Borodina, and T. Gloriozova, J. Chem. Inf. Comput. Sci., 39, 666 (1999).

  36. 36.

    V. V. Poroikov, D. A. Filimonov, Yu. V. Borodina, A. A. Lagunin, and A. Kos, J. Chem. Inf. Comput. Sci., 40, 1349 (2000).

  37. 37.

    V. A. Trapkov, A. P. Budunova, O. A. Burova, D. A. Filimonov, and V. V. Poroikov, Voprosy Med. Khim., 43, 39 (1997).

  38. 38.

    A. Geronikaki, V. Poroikov, D. Hadjipavlou-Litina, D. Filimonov, A. Lagunin, and R. Mgonzo, Quant. Struct.-Act. Relat., 18, 16 (1999).

  39. 39.

    V. V. Poroikov, D. A. Filimonov, W.-D. Ihlenfeldt, T. A. Gloriozova, A. A. Lagunin, Yu. V. Borodina, A.V. Stepanchikova, and M. C. Nicklaus, J. Chem. Inf. Comput. Sci., 43, 228 (2003).

  40. 40.

    A. Geronikaki, J. Dearden, D. Filimonov, I. Galaeva, T. Garibova, T. Gloriozova, V. Krajneva, A. Lagunin, F. Macaev, G. Molodavkin, V. Poroikov, S. Pogrebnoi, F. Shepeli, T. Voronina, M. Tsitlakidou, and L. Vlad, J. Med. Chem., 47, 2870 (2004).

  41. 41.

    A. Geronikaki, S. Vasilevsky, D. Hadjipavlou-Litina, A. Lagunin, and V. Poroikov, Khim. Geterotsikl. Soedin., 769 (2006). [Chem. Heterocycl. Compd., 42, 675 (2006)].

  42. 42.

    A. A. Lagunin, O. A. Gomazkov, D. A. Filimonov, T. A. Gureeva, E. A. Dilakyan, E. V. Kugaevskaya, Yu. E. Elisseeva, N. I. Solovyeva, and V. V. Poroikov, J. Med. Chem., 46, 3326 (2003).

  43. 43.

    A. A. Geronikaki, A. A. Lagunin, D. I. Hadjipavlou-Litina, P. T. Elefteriou, D. A. Filimonov, V. V. Poroikov, I. Alam, and A. K. Saxena, J. Med. Chem., 51, 1601 (2008).

  44. 44.

    V. Poroikov, D. Akimov, E. Shabelnikova, and D. Filimonov, SAR QSAR Environ. Res., 12, 327 (2001).

  45. 45.

    S. A. Kryzhanovskii, R. M. Salimov, A. A. Lagunin, D. A. Filimonov, T. A. Gloriozova, and V. V. Poroikov, Khim.-farm. Zh., 45, No. 10, 25 (2011).

  46. 46.

    V. Poroikov, D. Filimonov, A. Lagunin, T. Gloriozova, and A. Zakharov, SAR QSAR Environ. Res., 18, 101 (2007).

  47. 47.

    S. M. Ivanov, A. A. Lagunin, A. V. Zakharov, D. A. Filimonov, and V. V. Poroikov, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 7, 40 (2013).

  48. 48.

    A. Dalby, J. G. Nourse, W. D. Hounshell, A. K. I. Gushurst, D. L. Grier, B. A. Leland, and J. Laufer, J. Chem. Inf. Comput. Sci., 32, 244 (1992).

  49. 49.

    A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, Bioinformatics, 16, 747 (2000).

  50. 50.

    A. V. Sadym, A. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Khim.-farm. Zh., 36, No. 10, 21 (2002).

  51. 51.

    A. Sadym, A. Lagunin, D. Filimonov, and V. Poroikov, SAR QSAR Environ. Res., 14, 339 (2003).

  52. 52.

    A. Geronikaki, D. Druzhilovsky, A. Zakharov, and V. Poroikov, SAR QSAR Environ. Res., 19, 27 (2008).

  53. 53.

    PASS Online, http://www.way2drug.com/passonline.

  54. 54.

    D. Weininger, J. Chem. Inf. Comput. Sci., 28, 31 (1988).

  55. 55.

    http://www.chemaxon.com.

  56. 56.

    http://www.chemspider.com/.

  57. 57.

    http://bioinformatics.charite.de/superpred/.

  58. 58.

    http://cpi.bio-x.cn/drar/.

  59. 59.

    D. Filimonov, A. Lagunin, A. Rudik, D. Druzhilovsky, S. Ivanov, P. Pogodin, and V. Poroikov, in: Abstracts of the 19th European Symposium on Quantitative Structure-Activity Relationships, Vienna, Austria, August 26-30, 2012, p. 60.

  60. 60.

    C. B-Rao, A. Kulkarni-Almeida, K. V. Katkar, S. Khanna, U. Ghosh, A. Keche, P. Shah, A. Srivastava, V. Korde, K. V. S. Nemmani, N. J. Deshmukh, A. Dixit, M. K. Brahma, U. Bahirat, L. Doshi, R. Sharma, and H. Sivaramakrishnan, Bioorg. Med. Chem., 20, 2930 (2012).

  61. 61.

    D. Verbanac, S. C. Jain, N. Jain, M. Chand, H. Čipčić Paljetak, M. Matijašić, M. Perić, V. Stepanić, and L. Saso, Bioorg. Med. Chem., 20, 3180 (2012).

  62. 62.

    A. Kumar, P. Lohan, D. K. Aneja, G. K. Gupta, D. Kaushik, and O. Prakash, Eur. J. Med. Chem., 50, 81 (2012).

  63. 63.

    I. Shcherbakova, Khim. Geterotsikl. Soedin., 6 (2013). [Chem. Heterocycl. Compd., 49, 2 (2013)].

  64. 64.

    http://www.cerep.fr.

  65. 65.

    http://www.kinomescan.com.

  66. 66.

    P. Eleftheriou, A. Geronikaki, D. Hadjipavlou-Litina, P. Vicini, O. Filz, D. Filimonov, V. Poroikov, S. S. Chaudhaery, K. K. Roy, and A. Saxena, Eur. J. Med. Chem., 47, 111 (2012).

  67. 67.

    A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Curr. Pharm. Des., 16, 1703 (2010).

  68. 68.

    J. Frearson and P. Wyatt, Expert Opin. Drug Discovery, 5, 909 (2010).

  69. 69.

    W. Rhodes, J. Transl. Med., 10 (Suppl. 2), A42 (2012).

  70. 70.

    D. M. Huryn, L. O. Resnick, and P. Wipf, J. Med. Chem., 56, 7161 (2013).

  71. 71.

    S. Ekins and B. A. Bunin, in: S. Cortagere (editor), In Silico Models for Drug Discovery, Series: Methods in Molecular Biology, Vol. 993, Humana Press, New York (2013), p. 139.

Download references

Author information

Correspondence to V. V. Poroikov.

Additional information

This work was supported by the Russian Foundation for Basic Research (grant 12-07-00597-a).

Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 3, pp. 483-499, March, 2014.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 864 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Filimonov, D.A., Lagunin, A.A., Gloriozova, T.A. et al. Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource . Chem Heterocycl Comp 50, 444–457 (2014). https://doi.org/10.1007/s10593-014-1496-1

Download citation

Keywords

  • PASS Online
  • biological activity
  • computer prediction
  • organic compounds
  • pharmacologically active compounds
  • web resource